3 Oncology, Medical University Clinic, Kantonsspital Baselland, Liestal ... Journal of Nuclear Medicine (subscription) The aim of this study was to determine the maximum tolerated dose (MTD) and to explore the clinical response to 177Lu-DOTA-rituximab in the treatment of patients with relapsed follicular, mantle cell, or other indolent lymphomas such as marginal zone ... |
